Gsk - A Case Study On The Strategy Of “Merger Of Equals” In Ethical Pharmaceuticals
AbstractThis case summarises events leading to the creation of a global giant. The merger of Glaxo Wellcome and SmithKline Beecham had implications that went beyond the UK, where both companies were domiciled. The new company sought to take residence in the US but anti-trust authorities kept the companies formally apart for more than a year as they examined every aspect of the deal. The case invites readers to consider the process of integration as a general strategy, as well as the expectations, deliberations and motivation of managers and shareholders in doing so.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoPaper provided by EconWPA in its series Industrial Organization with number 0211017.
Length: 16 pages
Date of creation: 10 Nov 2002
Date of revision:
Note: Type of Document - pdf; to print on HP/PostScript/Franciscan monk; pages: 16
Contact details of provider:
Web page: http://18.104.22.168
Find related papers by JEL classification:
- L - Industrial Organization
This paper has been announced in the following NEP Reports:
- NEP-ALL-2002-11-18 (All new papers)
- NEP-COM-2002-11-18 (Industrial Competition)
- NEP-HEA-2002-11-18 (Health Economics)
- NEP-HIS-2002-11-18 (Business, Economic & Financial History)
- NEP-IND-2002-11-18 (Industrial Organization)
You can help add them by filling out this form.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (EconWPA).
If references are entirely missing, you can add them using this form.